Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sha Zhao

Showing results (351-360 of 380) with videos related to

Pageof 38
Sort By:
Nature Communications|January 9, 2025
Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cellsLi-Xian Yang, Chuangye Qi, Si Lu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancerXiaozhen Liu, Tao Jiang, Wei Li, et al.
JCI Insight|February 23, 2026
A machine learning-based triage system for systemic EBV-positive T/NK cell lymphoproliferative diseases of childhoodPujun Guan, Zihang Chen, Hanze Dong, et al.
Translational Lung Cancer Research|September 21, 2020
Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitorsSangtian Liu, Fei Zhou, Zhiyu Liu, et al.
Medcomm|July 29, 2025
Camrelizumab, an Anti-PD-1 Monoclonal Antibody, Plus Carboplatin and Nab-Paclitaxel as First-Line Setting for Extensive-Stage Small-Cell Lung Cancer: A Phase 2 Trial and Biomarker AnalysisJia Yu, Deyu Cai, Sha Zhao, et al.
Oncotargets and Therapy|May 12, 2021
Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung AdenocarcinomaHao Wang, Shanhao Chen, Die Meng, et al.
Cancer Immunology Research|February 14, 2019
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung CancerSha Zhao, Shengxiang Ren, Tao Jiang, et al.
Plos One|July 7, 2011
Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44Jiang-Sha Zhao, Wen-Jie Li, Di Ge, et al.
Journal of Hepatology|July 23, 2013
All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancerYang Zhang, Dong-xian Guan, Jie Shi, et al.
BMC Neurology|February 9, 2020
Better efficacy in differentiating WHO grade II from III oligodendrogliomas with machine-learning than radiologist's reading from conventional T1 contrast-enhanced and fluid attenuated inversion recovery imagesSha-Sha Zhao, Xiu-Long Feng, Yu-Chuan Hu, et al.
Pageof 38

Showing results (351-360 of 380) with videos related to

Sort By:
Pageof 38
Nature Communications|January 9, 2025
Alleviation of liver fibrosis by inhibiting a non-canonical ATF4-regulated enhancer program in hepatic stellate cellsLi-Xian Yang, Chuangye Qi, Si Lu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancerXiaozhen Liu, Tao Jiang, Wei Li, et al.
JCI Insight|February 23, 2026
A machine learning-based triage system for systemic EBV-positive T/NK cell lymphoproliferative diseases of childhoodPujun Guan, Zihang Chen, Hanze Dong, et al.
Translational Lung Cancer Research|September 21, 2020
Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitorsSangtian Liu, Fei Zhou, Zhiyu Liu, et al.
Medcomm|July 29, 2025
Camrelizumab, an Anti-PD-1 Monoclonal Antibody, Plus Carboplatin and Nab-Paclitaxel as First-Line Setting for Extensive-Stage Small-Cell Lung Cancer: A Phase 2 Trial and Biomarker AnalysisJia Yu, Deyu Cai, Sha Zhao, et al.
Oncotargets and Therapy|May 12, 2021
Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung AdenocarcinomaHao Wang, Shanhao Chen, Die Meng, et al.
Cancer Immunology Research|February 14, 2019
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung CancerSha Zhao, Shengxiang Ren, Tao Jiang, et al.
Plos One|July 7, 2011
Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44Jiang-Sha Zhao, Wen-Jie Li, Di Ge, et al.
Journal of Hepatology|July 23, 2013
All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancerYang Zhang, Dong-xian Guan, Jie Shi, et al.
BMC Neurology|February 9, 2020
Better efficacy in differentiating WHO grade II from III oligodendrogliomas with machine-learning than radiologist's reading from conventional T1 contrast-enhanced and fluid attenuated inversion recovery imagesSha-Sha Zhao, Xiu-Long Feng, Yu-Chuan Hu, et al.
Pageof 38